Загрузка...
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
Internal tandem duplications within the juxtamembrane domain of fms-like tyrosine kinase 3 (FLT3-ITD) occur in acute myeloid leukemia (AML) cells of 20-25% of patients and are associated with poor treatment outcomes. FLT3 inhibitors have been developed, but have had limited clinical efficacy due to...
Сохранить в:
| Опубликовано в: : | Cancer Lett |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528833/ https://ncbi.nlm.nih.gov/pubmed/30953707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.03.048 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|